Results 61 to 70 of about 62,886 (320)

Challenges in pharmacovigilance

Indian Journal of Pharmacology, 2010
The National Pharmacovigilance Programme of India (NPVI) has recently been launched. A renewed effort, yet, a right step in the right direction, something that is our own, designed, funded, and executed by us. It deserves not only our best wishes, but also a wholehearted cooperation.
openaire   +4 more sources

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding

British Journal of Clinical Pharmacology, EarlyView.
Aims We aimed to describe suspected adverse drug reactions (ADRs) in infants resulting from medications transmitted through mothers' milk, as reported to the European ADR database, EudraVigilance. The research sought to understand the frequency, seriousness and nature of these ADRs to assess potential risks associated with maternal medication use ...
Ida M. Heerfordt, Ditte Resendal Gotfredsen, Henrik Horwitz, Anette Kirstine Stark, Jon Trærup Andersen, Christina Gade, Ulrik Lausten‐Thomsen, Rasmus Huan Olsen   +7 more
wiley   +1 more source

Pharmacovigilance system in Saudi Arabia

Saudi Pharmaceutical Journal, 2017
Pharmacovigilance plays an important role in ensuring that patients are receiving safe drugs. In Saudi Arabia, Saudi Food and Drug Authority, health institutions, marketing authorization holders and healthcare professional are involved in ...
Thamir M. Alshammari, Mohammed Alshakka, Hisham Aljadhey   +2 more
doaj   +1 more source

A multidisciplinary meeting for generating a personalized pharmaceutical plan for older adults at hospital discharge: the IATROPREV study

British Journal of Clinical Pharmacology, EarlyView.
Aims The French government's IATROPREV program has been designed to assess the effectiveness and safety of medications prescribed to older adults discharged from acute geriatric units. IATROPREV includes the implementation of a personalized pharmaceutical plan validated at a multidisciplinary meeting attended by the patient's geriatrician, family ...
Chloé Cornille, Aurélie Lenglet, Bertrand Decaudin, François Puisieux, Lisa Mondet, Anne Toulemonde, Sophie Gautier, Grégory Tempremant, Jean‐Paul Kornobis, Mathilde Dambrine, Thomas Renoncourt, Frédéric Bloch, Jean‐Baptiste Beuscart, the IATROPREV collaborative group   +13 more
wiley   +1 more source

The Future of Generic Biologics: Should the United States “Follow-On” the European Pathway? [PDF]

, 2008
The United States is embarking on a biotechnology drug revolution. In the last few decades, biotech drugs have saved millions of lives, and the market for these miracle cures continues to grow at an astronomical rate.
Kaldre, Ingrid
core   +4 more sources

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

Inquiry: The Journal of Health Care Organization, Provision, and Financing
Functional pharmacovigilance systems are vital to ensure patient safety. There is a paucity of information on the organizational functionality of pharmacovigilance program in Ethiopia.
Sisay Endale Biru MSc, Tesfa Marew Wallelign MSc, Teferi Gedif Fenta PhD   +2 more
doaj   +1 more source

Strengthening adverse drug reaction reporting in Nepal

Asian Journal of Medical Sciences, 2015
Pharmacovigilance in Nepal is still in infancy. Till date only healthcare professionals are involved and the problem of underreporting is seen.
Nisha Jha
doaj   +1 more source

The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study

British Journal of Clinical Pharmacology, EarlyView.
Aims Several methods exist to identify hospital admissions related to adverse drug events (ADEs). Clinical adjudication by healthcare professionals is the gold standard but is labour‐intensive. Spontaneous reporting and routinely collected healthcare data using a set of International Classification of Diseases (ICD) codes often underestimate the ...
Zuzana Juhásová, Fatma Karapinar‐Çarkit, Daniala L. Weir   +2 more
wiley   +1 more source

Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019

Infectious Diseases and Therapy
Introduction Adult respiratory syncytial virus (RSV) burden is underestimated due to non-specific symptoms, limited standard-of-care and delayed testing, reduced diagnostic test sensitivity—particularly when using single diagnostic specimen—when compared
Marianna Mitratza, Malak Elsobky, Caihua Liang, Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Worku Biyadgie Ewnetu, Pimnara Peerawaranun, Thao Mai Phuong Tran, Charles Nuttens, Ana Gabriela Grajales, Sazini Nzula, Bradford D. Gessner, Elizabeth Begier   +12 more
doaj   +1 more source

Improving the Pharmacovigilance System in Medical Organisations as an Opportunity to Enhance the Quality of Pharmacotherapy

Безопасность и риск фармакотерапии
INTRODUCTION. It is essential to monitor the efficacy and safety of medicinal products as part of post-marketing surveillance to identify, assess, and prevent adverse drug reactions (ADRs).
M. V. Zhuravleva, S. Yu. Serebrova, E. V. Kuznetsova, T. R. Kameneva, A. V. Vlasova, A. B. Prokofiev, E. Yu. Demchenkova   +6 more
doaj   +1 more source